2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Vitreous Detachment: new trials by email Literature Review of Vitreous Detachment trials Research Report on Vitreous Detachment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR ocriplasmin 0.0625mg, ocriplasmin 0.125mg, Sham injection - Diabetic Retinopathy, Posterior Vitreous Detachment | Phase 2 | Terminated | ThromboGenics | 48 | 2015-12-01 | 2020-12-16 |
| Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations Ranibizumab - Retinal Vein Occlusion, Posterior Vitreous Detachment | Phase 2 | Completed | Barnes Retina Institute | 32 | 2009-04-01 | 2017-10-30 |
| Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment Vitrase - Vitreous Detachment, Diabetic Retinopathy | Phase 2 | Completed | Bausch & Lomb Incorporated | 10 | 2005-07-01 | 2013-03-15 |
Diabetic Retinopathy (2) · Disease Progression (1) · Retinal Vein Occlusion (1)
Cardiovascular Diseases (3) · Eye Diseases (3) · Retinal Diseases (3) · Vascular Diseases (3) · Diabetes Complications (2) · Diabetes Mellitus (2) · Diabetic Angiopathies (2) · Endocrine System Diseases (2) · Disease Attributes (1) · Embolism and Thrombosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Thrombosis (1) · Venous Thrombosis (1)
Chondroitinases and Chondroitin Lyases (1) · Ranibizumab (1) · microplasmin (1) · salicylhydroxamic acid (1)
Barnes Retina Institute (1) · Bausch & Lomb Incorporated (1) · ThromboGenics (1)
United States (3) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Spain (1) · United Kingdom (1)
Jon Williams, PhD (1) · Nancy M Holekamp, MD (1)
2015 (1)